Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform
Jonas Willmann(University of North Texas), Nicolaus Andratschke(University Hospital of Zurich), Stephanie Tandini-Lang(University of Zurich), N. Reynaert(Institut Jules Bordet), Carsten Nieder(UiT The Arctic University of Norway), Panagiotis Balermpas(Goethe University Frankfurt), Maximilian Niyazi(German Cancer Research Center), Coen Hurkmans(Radboud University Nijmegen), Brigitta G. Baumert(University of Bonn), Ane Appelt(University of Leeds), Orit Kaidar‐Person(Dana-Farber Cancer Institute), Morten Høyer(Aarhus University Hospital), Icro Meattini(Azienda Ospedaliero-Universitaria Careggi), Yvette M. van der Linden(Netherlands Comprehensive Cancer Organisation), Dirk De Ruysscher(Maastricht University Medical Centre), Philip Poortmans(Université Paris Sciences et Lettres)
Cited by 72
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k